期刊文献+

肾素-血管紧张素系统在糖尿病肾病肾脏足细胞损伤中的作用 被引量:10

Abnormality of Renin-Angiotensin System in Podocyte Dysfunction in Diabetic Kidney Disease
下载PDF
导出
摘要 糖尿病肾病(diabetic kidney disease,DKD)作为诱发终末期肾脏病(end-stage renal disease,ESRD)的主要原因,至今其病理机制仍不十分清楚。DKD病程中蛋白尿持续增多并伴随肾素-血管紧张素系统(renin-angiotensin system,RAS)过度激活。阻断RAS能改善蛋白尿,有良好的临床肾脏保护作用。足细胞表达RAS的各成员,作为肾小球滤过的最后屏障,其损伤与蛋白尿的发生关系密切。本文就RAS与足细胞损伤在DKD病理中作用作一简单综述。 Diabetic kidney disease (DKD) is currently the leading cause of end-stage renal disease (ESRD). DKD is stamped by proteinuria and progressive renal dysfunction. Excessive activation of RAS under hyperglycemic condition is associated with the development of DKD. Suppression of RAS markedly reduces proteinuria and retards progression of DKD in clinic. Podocyte forms the final barrier to protein in glomerular filtration. Podocyte injury leads to abnormality in glomerular filtration permeability, results in proteinuria. Various components of RAS have been identified to be expressed in podocyte. Here we re- viewed the progress on RAS in regulating the function of podocyte and progress of DKD.
出处 《生理科学进展》 CAS CSCD 北大核心 2011年第4期246-250,共5页 Progress in Physiological Sciences
关键词 糖尿病肾病 肾素-血管紧张素系统 足细胞 diabetic nephropathy renin-angiotensin system podocyte
  • 相关文献

参考文献24

  • 1Stitt-Cavanagh E, Macleod L, Kennedy C. The podocyte in diabetic kidney disease. Sci World J, 2009, 9 : 1127- 1139.
  • 2Nakamura T, Ushiyama C, Suzuki S, et al. Urinary excre- tion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant,2000, 15 : 1379 - 1383.
  • 3Davis BJ, Cao Z, de Gasparo M, et al. Disparate effects of angiotensin I! antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: po- tential role of nephrin. J Hypertens, 2003, 21 - 209 -216.
  • 4Kakizawa H, Itoh Y, Imamura S, et al. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist. Horm Metab Res, 2004, 36 : 458 -464.
  • 5Sung SH, Ziyadeh FN, Wang A, et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albu- minutia in mice. J Am Soc Nephrol, 2006, 17 : 3093 3104.
  • 6Liebau MC, Lang D, Bohm J, et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol,2006, 290 : F710 - F719.
  • 7Durvasula RV, Shankland SJ. Activation of a local renin an- glotensin system in podocytes by glucose. Am J Physiol Re- nod Physiol,2008, 294 : F830 - F839.
  • 8Sebekova K, Lill M, Boor P, et al. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. Am J Nephrol,2009, 29 : 164 - 170.
  • 9Jaimes EA, Hua P, Tian RX, et al. Human glomerular en- dothelium: interplay among glucose, free fatty acids, angio- tensin II, and oxidative stress. Am J Physiol Renal Physiol, 2010, 298 : F125 - F132.
  • 10Banday AA, Lokhandwala MF. Oxidative stress causes re- nal angiotensin II type 1 receptor upregulation, Na +/H + exchanger 3 overstimulation, and hypertension. Hyperten- sion,2011, 57 : 452 -459.

同被引文献134

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部